CytRx Corporation, a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, has announced that study results demonstrated that arimoclomol exhibited both statistically significant
OriGene Technologies has released 5,000 purified human proteins, representing comprehensive offering of human cell produced human proteins. Reportedly, OriGene’s recombinant proteins are purified from HEK293 cells transiently transfected
Warner Chilcott has proposed to acquire Procter & Gamble’s prescription-drug business. Warner Chilcott is likely to pay $3 billion for the business unit. Wall Street Journal has reported
PerkinElmer has opened a second specialized Good Manufacturing Practice (GMP) services facility. The Company has claimed that it has launched this capability in response to increasing demand for
Eric Shinseki, secretary of Veterans Affairs, is planing to lease 2.4 acres to a private-sector medical facility. The lease is in exchange for construction of building for the
Foamix has received US Patent No. 7575739 pertaining to its foam technology. The patent covers foam compositions, suitable for the treatment of heat and chemical burns, wounds, bacterial,
Santaris has signed a multi-year worldwide strategic alliance with Shire to discover and develop new RNA-based medicines to treat rare genetic disorders. The alliance will use Santaris’ proprietary
Synexus has acquired three more clinical trial centres in Poland. Dr. Andrzej Opadczuk will continue to manage the centres and will report to Dr. Christian Tueni, vice president,
Simcere has signed a strategic partnership with Sun Yat-Sen University Cancer Center in China. Under the agreement, Simcere and Sun Yat-Sen University Cancer Center will cooperate on researching
Nutra Pharma, a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has submitted final packaging and labeling to the Food and Drug
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.